论文部分内容阅读
目的:探讨分析孕妇分娩前凝血、抗凝、纤溶指标的变化及相关检验在孕妇时及分娩后的参考价值及临床意义。方法:选取2013年6月至2014年3月我院妇产科收治的孕37至41周孕妇63例,于分娩前对其进行凝血、抗凝、纤溶指标等指标的检验,并与我院体检健康妇女做对比,分析分娩前这些指标的临床意义。结果:PT、PT-INR、FIB、AT-Ⅲ、FDP、TT、D-D观察组与对照组比较,差异有统计学意义,P<0.05。APTT值组间比较无差异显著性,P>0.05。结论:分娩前凝血、抗凝、纤溶指标的检查,对于分析孕妇凝血状况有指导性意义,可提高警惕,减少和预防产后出血的发生。
Objective: To investigate the changes of coagulation, anticoagulation and fibrinolysis in pregnant women before delivery and the reference value and clinical significance of the correlation test in pregnant women and after delivery. Methods: From June 2013 to March 2014, 63 pregnant women of 37-41 weeks of gestation admitted to our department of gynecology and obstetrics from June 2013 to March 2014 were tested for coagulation, anticoagulation and fibrinolysis before delivery, Hospital healthy women to do a comparison, analysis of the clinical significance of these indicators before delivery. Results: There was significant difference between the PT, PT-INR, FIB, AT-Ⅲ, FDP, TT and D-D observation groups and the control group, P <0.05. There was no significant difference between APTT group, P> 0.05. Conclusion: The examination of coagulation, anticoagulation and fibrinolysis before delivery may be instructive for the analysis of coagulation status in pregnant women, which may increase vigilance and reduce and prevent the occurrence of postpartum hemorrhage.